Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study

BACKGROUND: Diabetic nephropathy (DN) is characterized by albuminuria, hypertension, and a progressive decline in glomerular filtration rate. The 3-hydroxy-3-methylglutaryl coenzyme A is a well-known agent that is active in lowering total plasma and low-density lipoprotein cholesterol (LDL-C) levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadighi, Alireza, Safa, Javid, Vatankhah, Amir-Mansour, Ghorashi, Sona, Aharilahagh, Aida, Davari-Farid, Sina, Nezami-Nargabad, Ourmaan, Naghavi-Behzad, Mohammad, Piri, Reza, Pishahang, Parinaz, Babapoor-Farrokhran, Savalan, Fakour, Sanam, Ghodratnezhad-Azar, Nastaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036295/
https://www.ncbi.nlm.nih.gov/pubmed/27833243
http://dx.doi.org/10.4103/0300-1652.190600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036295/
https://www.ncbi.nlm.nih.gov/pubmed/27833243
http://dx.doi.org/10.4103/0300-1652.190600

Ejemplares similares